From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin
Inflammopharmacology · 2026-02 · 34 (2) · 919-950
DOI: 10.1007/s10787-025-02090-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 09.01.2026. Verfasst von Heba R Ghaiad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. heba.mosalam@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Astaxanthin, a xanthophyll carotenoid derived primarily from Hematococcus lacustris , has been proposed as a potent bioactive compound demonstrating wide therapeutic applicability. In addition to its distinct molecular structure, astaxanthin has exceptional antioxidant property, surpassing that of other carotenoids and conventional antioxidants, while also exerting robust anti-inflammatory effects. The present review focuses on the current evidence of the complex multifaceted therapeutic actions of astaxanthin, including cardiovascular protection, neuroprotection, hepatoprotection, renal support, dermatological health, immune modulation, and emerging roles in metabolic disorders, reproductive health, and cancer prevention. Mechanistic insights highlight its potential to control key molecular mechanisms, including the NF-κB, Nrf2, MAPK, and TGF-β/Smad pathways, alongside the enhancement of endogenous antioxidant defenses. Preclinical and clinical findings have demonstrated benefits in conditions such as atherosclerosis, myocardial ischemia, nonalcoholic fatty liver disease, hypertension, Alzheimer’s disease, Parkinson’s disease, and inflammatory skin diseases. By integrating evidence drawn from molecular, experimental, and clinical studies, this review underscores astaxanthin’s potential as a complementary therapeutic agent and functional nutraceutical. The breadth of its bioactivity positions astaxanthin as a promising natural compound for targeted disease prevention and health promotion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. heba.mosalam@pharma.cu.edu.eg.
- Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. riham.adel@pharma.cu.edu.eg.
- Department of Pharmacology and Toxicology, College of Pharmacy, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt.
Förderung
- Cairo University
Zitieren
APA
Ghaiad, H. R., El-Shiekh, R. A., Atwa, A. M., Mustafa, A. M., Elgindy, A. M., Alkabbani, M. A., Elkady, W. A., & Ibrahim, K. M. (2026). From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin. Inflammopharmacology, 34(2), 919-950. https://doi.org/10.1007/s10787-025-02090-5
Vancouver
Ghaiad HR, El-Shiekh RA, Atwa AM, Mustafa AM, Elgindy AM, Alkabbani MA, et al. From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin. Inflammopharmacology. 2026;34(2):919-950. doi:10.1007/s10787-025-02090-5
BibTeX
@article{Ghaiad2026,
author = {Ghaiad, Heba R and El-Shiekh, Riham A and Atwa, Ahmed M and Mustafa, Aya M and Elgindy, Ali M and Alkabbani, Mahmoud Abdelrahman and Elkady, Weam A and Ibrahim, Kawther Magdy},
title = {From nutrition to therapeutics: the diverse inflammopharmacological and biomedical roles of astaxanthin},
journal = {Inflammopharmacology},
year = {2026},
volume = {34},
number = {2},
pages = {919--950},
doi = {10.1007/s10787-025-02090-5}
}
EUVIMED